{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:39:05Z","timestamp":1793911145693,"version":"4.8.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371185"],"award-info":[{"award-number":["32371185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Science and Technology Plan Project","award":["23010504200"],"award-info":[{"award-number":["23010504200"]}]},{"name":"Shanghai Oriental Talents Program"},{"name":"Key Lab of Exercise and Health Sciences of Ministry of Education","award":["2025KF002"],"award-info":[{"award-number":["2025KF002"]}]},{"name":"Shanghai Key Lab of Human Performance","award":["11DZ2261100"],"award-info":[{"award-number":["11DZ2261100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"DOI":"10.1186\/s12986-026-01091-7","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:59:04Z","timestamp":1775127544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Paeoniflorin: a natural candidate for the treatment of metabolic diseases"],"prefix":"10.1186","volume":"23","author":[{"given":"Minghao","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"1091_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01439-y","volume":"8","author":"X Wu","year":"2023","unstructured":"Wu X, Xu M, Geng M, Chen S, Little PJ, Xu S, et al. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. Signal Transduct Target Ther. 2023;8:220.","journal-title":"Signal Transduct Target Ther"},{"key":"1091_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","volume":"25","author":"CB Newgard","year":"2017","unstructured":"Newgard CB. Metabolomics and metabolic diseases: where do we stand? Cell Metab. 2017;25:43\u201356.","journal-title":"Cell Metab"},{"key":"1091_CR3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.clpt.2006.02.014","volume":"79","author":"M Hermann","year":"2006","unstructured":"Hermann M, Bogsrud MP, Molden E, Asberg A, Mohebi BU, Ose L, Retterstol K. Exposure of Atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with Atorvastatin-induced myopathy. Clin Pharmacol Ther. 2006;79:532\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"1091_CR4","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/aje\/kwac021","volume":"191","author":"R Pradhan","year":"2022","unstructured":"Pradhan R, Patorno E, Tesfaye H, Schneeweiss S, Yin H, Franklin J, et al. Glucagon-like peptide 1 receptor agonists and risk of anaphylactic reaction among patients with type 2 diabetes: a multisite population-based cohort study. Am J Epidemiol. 2022;191:1352\u201367.","journal-title":"Am J Epidemiol"},{"key":"1091_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-8587(17)30320-0","volume":"5","author":"VA Fonseca","year":"2017","unstructured":"Fonseca VA, Lovre D. Pioglitazone versus sulfonylureas: cardiovascular outcomes with older diabetes drugs. Lancet Diabetes Endocrinol. 2017;5:845\u20137.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1091_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/2050640620919585","volume":"8","author":"A Laschtowitz","year":"2020","unstructured":"Laschtowitz A, de Veer RC, der Van Meer AJ, Schramm C. Diagnosis and treatment of primary biliary cholangitis. United Eur Gastroenterol J. 2020;8:667\u201374.","journal-title":"United Eur Gastroenterol J"},{"key":"1091_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2021.802196","volume":"12","author":"X Zheng","year":"2021","unstructured":"Zheng X, Yin M, Chu S, Yang M, Yang Z, Zhu Y, et al. Comparative elucidation of age, diameter, and pockmarks in roots of paeonia lactiflora Pall. (Shaoyao) by qualitative and quantitative methods. Front Plant Sci. 2021;12:802196.","journal-title":"Front Plant Sci"},{"key":"1091_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/jphp.13204","volume":"72","author":"Y Xiang","year":"2020","unstructured":"Xiang Y, Zhang Q, Wei S, Huang C, Li Z, Gao Y. Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities. J Pharm Pharmacol. 2020;72:483\u201395.","journal-title":"J Pharm Pharmacol"},{"key":"1091_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.934199","volume":"13","author":"W Guo","year":"2022","unstructured":"Guo W, Yao X, Cui R, Yang W, Wang L. Mechanisms of Paeoniaceae action as an antidepressant. Front Pharmacol. 2022;13:934199.","journal-title":"Front Pharmacol"},{"key":"1091_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jep.2013.08.017","volume":"149","author":"Y Ji","year":"2013","unstructured":"Ji Y, Wang T, Wei ZF, Lu GX, Jiang SD, Xia YF, et al. Paeoniflorin, the main active constituent of paeonia lactiflora roots, attenuates bleomycin-induced pulmonary fibrosis in mice by suppressing the synthesis of type I collagen. J Ethnopharmacol. 2013;149:825\u201332.","journal-title":"J Ethnopharmacol"},{"key":"1091_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00010","volume":"2","author":"DY He","year":"2011","unstructured":"He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional Chinese herbal medicine. Front Pharmacol. 2011;2:10.","journal-title":"Front Pharmacol"},{"key":"1091_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.113624","volume":"173","author":"L Peng","year":"2023","unstructured":"Peng L, Ma Z, Chu W, Jiang P, Fu Y, Wang P. Identification and hepatoprotective activity of total glycosides of Paeony with high content of Paeoniflorin extracted from paeonia lactiflora pall. Food Chem Toxicol. 2023;173:113624.","journal-title":"Food Chem Toxicol"},{"key":"1091_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1248\/cpb.11.762","volume":"11","author":"S Shibata","year":"1963","unstructured":"Shibata S, Tanaka O, Nagai M, Ishii T. Studies on the constituents of Japanese and Chinese crude drugs. Xii. Panaxadiol, a sapogenin of ginseng roots. Chem Pharm Bull (Tokyo). 1963;11:762\u20135.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"1091_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1122969","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Sun C, Zhang J, Hu L, Yu Z, Zhang X, et al. Protective effects of Paeoniflorin on cardiovascular diseases: a pharmacological and mechanistic overview. Front Pharmacol. 2023;14:1122969.","journal-title":"Front Pharmacol"},{"key":"1091_CR15","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/S0040-4020(01)82804-0","volume":"25","author":"N Aimi","year":"1969","unstructured":"Aimi N, Inaba M, Watanabe M, Shibata S. Chemical studies on the Oriental plant drugs. 23. Peoniflorin, a glucoside of Chinese Paeony root. Tetrahedron. 1969;25:1825\u201338.","journal-title":"Tetrahedron"},{"key":"1091_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107452","volume":"207","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of Paeoniflorin and total glucosides of Paeony. Pharmacol Ther. 2020;207:107452.","journal-title":"Pharmacol Ther"},{"key":"1091_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116772","volume":"176","author":"Y Lu","year":"2024","unstructured":"Lu Y, Yin L, Yang W, Wu Z, Niu J. Antioxidant effects of Paeoniflorin and relevant molecular mechanisms as related to a variety of diseases: a review. Biomed Pharmacother. 2024;176:116772.","journal-title":"Biomed Pharmacother"},{"key":"1091_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112800","volume":"149","author":"XZ Wang","year":"2022","unstructured":"Wang XZ, Xia L, Zhang XY, Chen Q, Li X, Mou Y, et al. The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: state-of-the-art. Biomed Pharmacother. 2022;149:112800.","journal-title":"Biomed Pharmacother"},{"key":"1091_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110505","volume":"130","author":"YX Zhou","year":"2020","unstructured":"Zhou YX, Gong XH, Zhang H, Peng C. A review on the pharmacokinetics of Paeoniflorin and its anti-inflammatory and immunomodulatory effects. Biomed Pharmacother. 2020;130:110505.","journal-title":"Biomed Pharmacother"},{"key":"1091_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.898955","volume":"13","author":"H Hong","year":"2022","unstructured":"Hong H, Lu X, Wu C, Chen J, Chen C, Zhang J, et al. A review for the pharmacological effects of Paeoniflorin in the nervous system. Front Pharmacol. 2022;13:898955.","journal-title":"Front Pharmacol"},{"key":"1091_CR21","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2024.06.029","volume":"187","author":"ED Abel","year":"2024","unstructured":"Abel ED, Gloyn AL, Evans-Molina C, Joseph JJ, Misra S, Pajvani UB, et al. Diabetes mellitus-progress and opportunities in the evolving epidemic. Cell. 2024;187:3789\u2013820.","journal-title":"Cell"},{"key":"1091_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S2213-8587(21)00113-3","volume":"9","author":"MA Nauck","year":"2021","unstructured":"Nauck MA, Wefers J, Meier JJ. Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. Lancet Diabetes Endocrinol. 2021;9:525\u201344.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1091_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(24)00339-5","volume":"13","author":"A Bonnefond","year":"2025","unstructured":"Bonnefond A, Florez JC, Loos RJF, Froguel P. Dissection of type 2 diabetes: a genetic perspective. Lancet Diabetes Endocrinol. 2025;13:149\u201364.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1091_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100275","volume":"8","author":"S Demir","year":"2021","unstructured":"Demir S, Nawroth PP, Herzig S, Ekim Ustunel B. Emerging targets in type 2 diabetes and diabetic complications. Adv Sci. 2021;8:e2100275.","journal-title":"Adv Sci"},{"key":"1091_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S2213-8587(24)00127-X","volume":"12","author":"M Abdul-Ghani","year":"2024","unstructured":"Abdul-Ghani M, Maffei P, DeFronzo RA. Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes. Lancet Diabetes Endocrinol. 2024;12:674\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1091_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.metabol.2014.10.019","volume":"64","author":"S Pereira","year":"2015","unstructured":"Pereira S, Breen DM, Naassan AE, Wang PY, Uchino H, Fantus IG, Carpentier AC, Gutierrez-Juarez R, Brindley DN, Lam TK, Giacca A. In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity. Metabolism. 2015;64:315\u201322.","journal-title":"Metabolism"},{"key":"1091_CR27","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1002\/jcb.22173","volume":"113","author":"B Jiang","year":"2012","unstructured":"Jiang B, Qiao J, Yang Y, Lu Y. Inhibitory effect of Paeoniflorin on the inflammatory vicious cycle between adipocytes and macrophages. J Cell Biochem. 2012;113:2560\u20136.","journal-title":"J Cell Biochem"},{"key":"1091_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.fitote.2013.08.010","volume":"91","author":"P Kong","year":"2013","unstructured":"Kong P, Chi R, Zhang L, Wang N, Lu Y. Effects of Paeoniflorin on tumor necrosis factor-alpha-induced insulin resistance and changes of adipokines in 3T3-L1 adipocytes. Fitoterapia. 2013;91:44\u201350.","journal-title":"Fitoterapia"},{"key":"1091_CR29","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1007\/s00125-010-1882-x","volume":"53","author":"Y Liu","year":"2010","unstructured":"Liu Y, Tanabe K, Baronnier D, Patel S, Woodgett J, Cras-Meneur C, Permutt MA. Conditional ablation of Gsk-3beta in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice. Diabetologia. 2010;53:2600\u201310.","journal-title":"Diabetologia"},{"key":"1091_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.biopha.2017.03.087","volume":"90","author":"Z Ma","year":"2017","unstructured":"Ma Z, Liu H, Wang W, Guan S, Yi J, Chu L. Paeoniflorin suppresses lipid accumulation and alleviates insulin resistance by regulating the Rho kinase\/IRS-1 pathway in palmitate-induced HepG2Cells. Biomed Pharmacother. 2017;90:361\u20137.","journal-title":"Biomed Pharmacother"},{"key":"1091_CR31","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liang Y, Liu H, Huang Y, Li H, Chen B. Paeoniflorin attenuates gestational diabetes via Akt\/mTOR pathway in a rat model. Food Nutr Res. 2020;64:4362.","DOI":"10.29219\/fnr.v64.4362"},{"key":"1091_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/diacare.27.3.813","volume":"27","author":"JC Pickup","year":"2004","unstructured":"Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27:813\u201323.","journal-title":"Diabetes Care"},{"key":"1091_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1172\/JCI88877","volume":"127","author":"K Eguchi","year":"2017","unstructured":"Eguchi K, Nagai R. Islet inflammation in type 2 diabetes and physiology. J Clin Invest. 2017;127:14\u201323.","journal-title":"J Clin Invest"},{"key":"1091_CR34","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1161\/01.ATV.0000183883.72263.13","volume":"25","author":"T Suganami","year":"2005","unstructured":"Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005;25:2062\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1091_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113429","volume":"422","author":"C Luo","year":"2023","unstructured":"Luo C, Yang D, Hou C, Tan T, Chao C. Paeoniflorin protects NOD mice from T1D through regulating gut microbiota and TLR4 mediated myD88\/TRIF pathway. Exp Cell Res. 2023;422:113429.","journal-title":"Exp Cell Res"},{"key":"1091_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010018","author":"J Dawi","year":"2024","unstructured":"Dawi J, Misakyan Y, Affa S, Kades S, Narasimhan A, Hajjar F, et al. Oxidative stress, glutathione insufficiency, and inflammatory pathways in type 2 diabetes mellitus: implications for therapeutic interventions. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines13010018.","journal-title":"Biomedicines"},{"key":"1091_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejphar.2019.03.025","volume":"853","author":"Y Liu","year":"2019","unstructured":"Liu Y, Han J, Zhou Z, Li D. Paeoniflorin protects pancreatic beta cells from STZ-induced damage through inhibition of the p38 MAPK and JNK signaling pathways. Eur J Pharmacol. 2019;853:18\u201324.","journal-title":"Eur J Pharmacol"},{"key":"1091_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17:585\u2013607.","journal-title":"Nat Rev Cardiol"},{"key":"1091_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","journal-title":"J Hematol Oncol"},{"key":"1091_CR40","doi-asserted-by":"publisher","first-page":"612","DOI":"10.7150\/ijms.88476","volume":"21","author":"Z Song","year":"2024","unstructured":"Song Z, Wang J, Zhang L. Ferroptosis: a new mechanism in diabetic cardiomyopathy. Int J Med Sci. 2024;21:612\u201322.","journal-title":"Int J Med Sci"},{"key":"1091_CR41","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.7150\/thno.98172","volume":"14","author":"Y Yong","year":"2024","unstructured":"Yong Y, Yan L, Wei J, Feng C, Yu L, Wu J, et al. A novel ferroptosis inhibitor, Thonningianin A, improves alzheimer\u2019s disease by activating GPX4. Theranostics. 2024;14:6161\u201384.","journal-title":"Theranostics"},{"key":"1091_CR42","doi-asserted-by":"publisher","first-page":"C724","DOI":"10.1152\/ajpcell.00565.2023","volume":"326","author":"H Wu","year":"2024","unstructured":"Wu H, Zhang P, Zhou J, Hu S, Hao J, Zhong Z, Yu H, Yang J, Chi J, Guo H. Paeoniflorin confers ferroptosis resistance by regulating the gut microbiota and its metabolites in diabetic cardiomyopathy. Am J Physiol Cell Physiol. 2024;326:C724\u201341.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1091_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7326\/0003-4819-126-4-199702150-00006","volume":"126","author":"D Aronson","year":"1997","unstructured":"Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med. 1997;126:296\u2013306.","journal-title":"Ann Intern Med"},{"key":"1091_CR44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2016.06.092","volume":"220","author":"T Sun","year":"2016","unstructured":"Sun T, Guo Z, Liu CJ, Li MR, Li TP, Wang X, Yuan DJ. Preservation of CGRP in myocardium attenuates development of cardiac dysfunction in diabetic rats. Int J Cardiol. 2016;220:226\u201334.","journal-title":"Int J Cardiol"},{"key":"1091_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177021","volume":"984","author":"YR Shen","year":"2024","unstructured":"Shen YR, Cheng L, Zhang DF. TRPV1: a novel target for the therapy of diabetes and diabetic complications. Eur J Pharmacol. 2024;984:177021.","journal-title":"Eur J Pharmacol"},{"key":"1091_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-016-0085-7","volume":"6","author":"F Han","year":"2016","unstructured":"Han F, Zhou D, Yin X, Sun Z, Han J, Ye L, et al. Paeoniflorin protects diabetic mice against myocardial ischemic injury via the transient receptor potential vanilloid 1\/calcitonin gene-related peptide pathway. Cell Biosci. 2016;6:37.","journal-title":"Cell Biosci"},{"key":"1091_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrendo.2009.266","volume":"6","author":"A Flyvbjerg","year":"2010","unstructured":"Flyvbjerg A. Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. Nat Rev Endocrinol. 2010;6:94\u2013101.","journal-title":"Nat Rev Endocrinol"},{"key":"1091_CR48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-024-08283-2","volume":"637","author":"A Cuevas-Navarro","year":"2025","unstructured":"Cuevas-Navarro A, Pourfarjam Y, Hu F, Rodriguez DJ, Vides A, Sang B, et al. Pharmacological restoration of GTP hydrolysis by mutant RAS. Nature. 2025;637:224\u20139.","journal-title":"Nature"},{"key":"1091_CR49","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1507\/endocrj.EJ24-0122","volume":"71","author":"W Yu","year":"2024","unstructured":"Yu W, Jiang H. Paeoniflorin alleviates high glucose-induced endothelial cell apoptosis in diabetes mellitus by inhibiting HRAS-activated RAS pathway. Endocr J. 2024;71:1045\u201353.","journal-title":"Endocr J"},{"key":"1091_CR50","doi-asserted-by":"publisher","first-page":"42605","DOI":"10.1039\/D0RA02036B","volume":"10","author":"Y Huang","year":"2020","unstructured":"Huang Y, Wang JS, Yang L, Yue L, Zhang L, Zhang YH, Song YW, Li D, Yang Z. Paeoniflorin ameliorates glycemic variability-induced oxidative stress and platelet activation in HUVECs and DM rats. RSC Adv. 2020;10:42605\u201312.","journal-title":"RSC Adv"},{"key":"1091_CR51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1210\/endrev\/bnz010","volume":"41","author":"Y Lytvyn","year":"2020","unstructured":"Lytvyn Y, Bjornstad P, van Raalte DH, Heerspink HL, Cherney DZI. The new biology of diabetic kidney disease-mechanisms and therapeutic implications. Endocr Rev. 2020;41:202\u201331.","journal-title":"Endocr Rev"},{"key":"1091_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bcp.2018.11.012","volume":"162","author":"J Seo","year":"2019","unstructured":"Seo J, Kim MW, Bae KH, Lee SC, Song J, Lee EW. The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics. Biochem Pharmacol. 2019;162:21\u201340.","journal-title":"Biochem Pharmacol"},{"key":"1091_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.966645","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Liu XQ, Jiang L, Huang YB, Zeng HX, Zhu QJ, et al. Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease. Front Pharmacol. 2022;13:966645.","journal-title":"Front Pharmacol"},{"key":"1091_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154400","volume":"106","author":"X Wang","year":"2022","unstructured":"Wang X, Jiang L, Liu XQ, Huang YB, Wang AL, Zeng HX, et al. Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway. Phytomedicine. 2022;106:154400.","journal-title":"Phytomedicine"},{"key":"1091_CR55","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.biopha.2017.03.016","volume":"89","author":"J Chen","year":"2017","unstructured":"Chen J, Zhao D, Zhu M, Zhang M, Hou X, Ding W, Sun S, Bu W, Feng L, Ma S, Jia X. Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE\/mTOR\/autophagy pathway. Biomed Pharmacother. 2017;89:1362\u20139.","journal-title":"Biomed Pharmacother"},{"key":"1091_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1681\/ASN.2009060615","volume":"22","author":"S Lee","year":"2011","unstructured":"Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011;22:317\u201326.","journal-title":"J Am Soc Nephrol"},{"key":"1091_CR57","first-page":"557","volume":"59","author":"J Fu","year":"2009","unstructured":"Fu J, Li Y, Wang L, Gao B, Zhang N, Ji Q. Paeoniflorin prevents diabetic nephropathy in rats. Comp Med. 2009;59:557\u201366.","journal-title":"Comp Med"},{"key":"1091_CR58","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","volume":"13","author":"T Kawai","year":"2006","unstructured":"Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13:816\u201325.","journal-title":"Cell Death Differ"},{"key":"1091_CR59","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.2147\/DDDT.S149504","volume":"11","author":"YX Shao","year":"2017","unstructured":"Shao YX, Xu XX, Wang K, Qi XM, Wu YG. Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway. Drug Des Devel Ther. 2017;11:3221\u201333.","journal-title":"Drug Des Devel Ther"},{"key":"1091_CR60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jep.2016.08.035","volume":"193","author":"YX Shao","year":"2016","unstructured":"Shao YX, Xu XX, Li YY, Qi XM, Wang K, Wu YG, Meng XM. Paeoniflorin inhibits high glucose-induced macrophage activation through TLR2-dependent signal pathways. J Ethnopharmacol. 2016;193:377\u201386.","journal-title":"J Ethnopharmacol"},{"key":"1091_CR61","doi-asserted-by":"publisher","first-page":"308","DOI":"10.5582\/bst.2017.01104","volume":"11","author":"T Zhang","year":"2017","unstructured":"Zhang T, Zhu Q, Shao Y, Wang K, Wu Y. Paeoniflorin prevents TLR2\/4-mediated inflammation in type 2 diabetic nephropathy. Biosci Trends. 2017;11:308\u201318.","journal-title":"Biosci Trends"},{"key":"1091_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.01.014","volume":"14","author":"J Wu","year":"2024","unstructured":"Wu J, Li K, Zhou M, Gao H, Wang W, Xiao W. Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. J Pharm Anal. 2024;14:100946.","journal-title":"J Pharm Anal"},{"key":"1091_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00566","volume":"10","author":"YX Shao","year":"2019","unstructured":"Shao YX, Gong Q, Qi XM, Wang K, Wu YG. Paeoniflorin ameliorates macrophage infiltration and activation by inhibiting the TLR4 signaling pathway in diabetic nephropathy. Front Pharmacol. 2019;10:566.","journal-title":"Front Pharmacol"},{"key":"1091_CR64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5582\/bst.2018.01009","volume":"12","author":"X Li","year":"2018","unstructured":"Li X, Wang Y, Wang K, Wu Y. Renal protective effect of Paeoniflorin by inhibition of JAK2\/STAT3 signaling pathway in diabetic mice. Biosci Trends. 2018;12:168\u201376.","journal-title":"Biosci Trends"},{"key":"1091_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203308","volume":"10","author":"F Huang","year":"2023","unstructured":"Huang F, Lu X, Yang Y, Yang Y, Li Y, Kuai L, et al. Microenvironment-based diabetic foot ulcer nanomedicine. Adv Sci. 2023;10:e2203308.","journal-title":"Adv Sci"},{"key":"1091_CR66","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","volume":"327","author":"K Schroder","year":"2010","unstructured":"Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science. 2010;327:296\u2013300.","journal-title":"Science"},{"key":"1091_CR67","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ddr.21763","volume":"82","author":"X Sun","year":"2021","unstructured":"Sun X, Wang X, Zhao Z, Chen J, Li C, Zhao G. Paeoniflorin inhibited nod-like receptor protein-3 inflammasome and NF-kappaB-mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR2. Drug Dev Res. 2021;82:404\u201311.","journal-title":"Drug Dev Res"},{"key":"1091_CR68","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","volume":"34","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Liu J, Duan H, Li R, Peng W, Wu C. Activation of Nrf2\/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res. 2021;34:43\u201363.","journal-title":"J Adv Res"},{"key":"1091_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.acthis.2020.151649","volume":"122","author":"X Sun","year":"2020","unstructured":"Sun X, Wang X, Zhao Z, Chen J, Li C, Zhao G. Paeoniflorin accelerates foot wound healing in diabetic rats though activating the Nrf2 pathway. Acta Histochem. 2020;122:151649.","journal-title":"Acta Histochem"},{"key":"1091_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2021.100139","volume":"12","author":"H Yang","year":"2021","unstructured":"Yang H, Song L, Sun B, Chu D, Yang L, Li M, et al. Modulation of macrophages by a paeoniflorin-loaded hyaluronic acid-based hydrogel promotes diabetic wound healing. Mater Today Bio. 2021;12:100139.","journal-title":"Mater Today Bio"},{"key":"1091_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102450","volume":"100","author":"A Nagayach","year":"2024","unstructured":"Nagayach A, Bhaskar R, Ghosh S, Singh KK, Han SS, Sinha JK. Advancing the understanding of diabetic encephalopathy through unravelling pathogenesis and exploring future treatment perspectives. Ageing Res Rev. 2024;100:102450.","journal-title":"Ageing Res Rev"},{"key":"1091_CR72","doi-asserted-by":"publisher","first-page":"18670","DOI":"10.1073\/pnas.1006586107","volume":"107","author":"H Du","year":"2010","unstructured":"Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS. Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model. Proc Natl Acad Sci U S A. 2010;107:18670\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1091_CR73","unstructured":"Dalal D, Singh L, Singh A. Desmethylglycitein attenuates Scopolamine-Induced cognitive deficits via Nrf-2 activation and IL-1\u03b2 suppression. Neurophysiology; 2025."},{"key":"1091_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.physbeh.2018.03.016","volume":"191","author":"D Wang","year":"2018","unstructured":"Wang D, Liu L, Li S, Wang C. Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive impairment in mice. Physiol Behav. 2018;191:12\u201320.","journal-title":"Physiol Behav"},{"key":"1091_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05909-7","volume":"14","author":"M Qu","year":"2023","unstructured":"Qu M, Zuo L, Zhang M, Cheng P, Guo Z, Yang J, et al. High glucose induces Tau hyperphosphorylation in hippocampal neurons via inhibition of ALKBH5-mediated Dgkh m(6)A demethylation: a potential mechanism for diabetic cognitive dysfunction. Cell Death Dis. 2023;14:385.","journal-title":"Cell Death Dis"},{"key":"1091_CR76","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.physbeh.2017.03.020","volume":"174","author":"X Sun","year":"2017","unstructured":"Sun X, Li S, Xu L, Wang H, Ma Z, Fu Q, Qu R, Ma S. Paeoniflorin ameliorates cognitive dysfunction via regulating SOCS2\/IRS-1 pathway in diabetic rats. Physiol Behav. 2017;174:162\u20139.","journal-title":"Physiol Behav"},{"key":"1091_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102346","author":"V Barone","year":"2024","unstructured":"Barone V, Surico PL, Cutrupi F, Mori T, Gallo Afflitto G, Di Zazzo A, et al. The role of immune cells and signaling pathways in diabetic eye disease: a comprehensive review. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12102346.","journal-title":"Biomedicines"},{"key":"1091_CR78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17:195\u2013206.","journal-title":"Nat Rev Endocrinol"},{"key":"1091_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.564077","volume":"11","author":"UM Kinuthia","year":"2020","unstructured":"Kinuthia UM, Wolf A, Langmann T. Microglia and inflammatory responses in diabetic retinopathy. Front Immunol. 2020;11:564077.","journal-title":"Front Immunol"},{"key":"1091_CR80","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s10753-017-0571-z","volume":"40","author":"SH Zhu","year":"2017","unstructured":"Zhu SH, Liu BQ, Hao MJ, Fan YX, Qian C, Teng P, et al. Paeoniflorin suppressed high Glucose-Induced retinal microglia MMP-9 expression and inflammatory response via inhibition of TLR4\/NF-kappaB pathway through upregulation of SOCS3 in diabetic retinopathy. Inflammation. 2017;40:1475\u201386.","journal-title":"Inflammation"},{"key":"1091_CR81","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20170695","author":"K Zeng","year":"2017","unstructured":"Zeng K, Feng QG, Lin BT, Ma DH, Liu CM. Effects of microRNA-211 on proliferation and apoptosis of lens epithelial cells by targeting SIRT1 gene in diabetic cataract mice. Biosci Rep. 2017. https:\/\/doi.org\/10.1042\/BSR20170695.","journal-title":"Biosci Rep"},{"key":"1091_CR82","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1080\/21655979.2021.2018534","volume":"13","author":"K Zeng","year":"2022","unstructured":"Zeng K, Xi W, Qiao Y, Huang X, Liu X. Paeoniflorin inhibits epithelial mesenchymal transformation and oxidative damage of lens epithelial cells in diabetic cataract via Sirtuin 1 upregulation. Bioengineered. 2022;13:5903\u201314.","journal-title":"Bioengineered"},{"key":"1091_CR83","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jep.2016.03.031","volume":"185","author":"X Yang","year":"2016","unstructured":"Yang X, Yao W, Shi H, Liu H, Li Y, Gao Y, Liu R, Xu L. Paeoniflorin protects Schwann cells against high glucose induced oxidative injury by activating Nrf2\/ARE pathway and inhibiting apoptosis. J Ethnopharmacol. 2016;185:361\u20139.","journal-title":"J Ethnopharmacol"},{"key":"1091_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108792","volume":"109","author":"A Wang","year":"2022","unstructured":"Wang A, Gong Y, Pei Z, Jiang L, Xia L, Wu Y. Paeoniflorin ameliorates diabetic liver injury by targeting the TXNIP-mediated NLRP3 inflammasome in db\/db mice. Int Immunopharmacol. 2022;109:108792.","journal-title":"Int Immunopharmacol"},{"key":"1091_CR85","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","volume":"17","author":"D Ferguson","year":"2021","unstructured":"Ferguson D, Finck BN. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat Rev Endocrinol. 2021;17:484\u201395.","journal-title":"Nat Rev Endocrinol"},{"key":"1091_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1494560","volume":"15","author":"YH Fan","year":"2024","unstructured":"Fan YH, Zhang S, Wang Y, Wang H, Li H, Bai L. Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2024;15:1494560.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1091_CR87","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jgr.2023.11.004","volume":"48","author":"W Wang","year":"2024","unstructured":"Wang W, Li K, Xiao W. The pharmacological role of ginsenoside Rg3 in liver diseases: a review on molecular mechanisms. J Ginseng Res. 2024;48:129\u201339.","journal-title":"J Ginseng Res"},{"key":"1091_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/nu15153433","author":"R Song","year":"2023","unstructured":"Song R, Hu M, Qin X, Qiu L, Wang P, Zhang X, et al. The roles of lipid metabolism in the pathogenesis of chronic diseases in the elderly. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15153433.","journal-title":"Nutrients"},{"key":"1091_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/nu10081024","author":"YC Li","year":"2018","unstructured":"Li YC, Qiao JY, Wang BY, Bai M, Shen JD, Cheng YX. Paeoniflorin ameliorates fructose-induced insulin resistance and hepatic steatosis by activating LKB1\/AMPK and AKT pathways. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10081024.","journal-title":"Nutrients"},{"key":"1091_CR90","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/med.1025","volume":"21","author":"AB Jones","year":"2001","unstructured":"Jones AB. Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond. Med Res Rev. 2001;21:540\u201352.","journal-title":"Med Res Rev"},{"key":"1091_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101109","volume":"83","author":"H Li","year":"2021","unstructured":"Li H, Yu XH, Ou X, Ouyang XP, Tang CK. Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Prog Lipid Res. 2021;83:101109.","journal-title":"Prog Lipid Res"},{"key":"1091_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/srep44819","volume":"7","author":"Z Ma","year":"2017","unstructured":"Ma Z, Chu L, Liu H, Wang W, Li J, Yao W, et al. Beneficial effects of Paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Sci Rep. 2017;7:44819.","journal-title":"Sci Rep"},{"key":"1091_CR93","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1248\/bpb.b14-00892","volume":"38","author":"L Zhang","year":"2015","unstructured":"Zhang L, Yang B, Yu B. Paeoniflorin protects against nonalcoholic fatty liver disease induced by a high-fat diet in mice. Biol Pharm Bull. 2015;38:1005\u201311.","journal-title":"Biol Pharm Bull"},{"key":"1091_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091653","author":"A Allameh","year":"2023","unstructured":"Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K. Oxidative stress in liver pathophysiology and disease. Antioxidants (Basel). 2023. https:\/\/doi.org\/10.3390\/antiox12091653.","journal-title":"Antioxidants (Basel)"},{"key":"1091_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.968717","volume":"13","author":"T Liu","year":"2022","unstructured":"Liu T, Zhang N, Kong L, Chu S, Zhang T, Yan G, et al. Paeoniflorin alleviates liver injury in hypercholesterolemic rats through the ROCK\/AMPK pathway. Front Pharmacol. 2022;13:968717.","journal-title":"Front Pharmacol"},{"key":"1091_CR96","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","volume":"58","author":"TM Leung","year":"2013","unstructured":"Leung TM, Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol. 2013;58:395\u20138.","journal-title":"J Hepatol"},{"key":"1091_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040365","author":"A Zisser","year":"2021","unstructured":"Zisser A, Ipsen DH, Tveden-Nyborg P. Hepatic stellate cell activation and inactivation in NASH-fibrosis-roles as putative treatment targets? Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9040365.","journal-title":"Biomedicines"},{"key":"1091_CR98","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1091_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S, et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduct Target Ther. 2024;9:332.","journal-title":"Signal Transduct Target Ther"},{"key":"1091_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155477","volume":"128","author":"T Lan","year":"2024","unstructured":"Lan T, Li P, Zhang SJ, Liu SY, Zeng XX, Chai F, et al. Paeoniflorin promotes PPARgamma expression to suppress HSCs activation by inhibiting EZH2-mediated histone H3K27 trimethylation. Phytomedicine. 2024;128:155477.","journal-title":"Phytomedicine"},{"key":"1091_CR101","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.intimp.2017.09.013","volume":"53","author":"J He","year":"2017","unstructured":"He J, Bai K, Hong B, Zhang F, Zheng S. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats. Int Immunopharmacol. 2017;53:56\u201362.","journal-title":"Int Immunopharmacol"},{"key":"1091_CR102","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcdb.2019.12.010","volume":"101","author":"M Lodyga","year":"2020","unstructured":"Lodyga M, Hinz B. TGF-beta1 - a truly transforming growth factor in fibrosis and immunity. Semin Cell Dev Biol. 2020;101:123\u201339.","journal-title":"Semin Cell Dev Biol"},{"key":"1091_CR103","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v16i9.9","author":"W-Z Li","year":"2017","unstructured":"Li W-Z, Wei Z-B. Mitigation of TGF-\u03b2\/Smad signaling pathway-associated liver fibrosis by paeoniflorin. Trop J Pharm Res. 2017. https:\/\/doi.org\/10.4314\/tjpr.v16i9.9.","journal-title":"Trop J Pharm Res"},{"key":"1091_CR104","first-page":"1012","volume":"10","author":"Z Hu","year":"2018","unstructured":"Hu Z, Qin F, Gao S, Zhen Y, Huang D, Dong L. Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-beta1\/Smads signaling pathway. Am J Transl Res. 2018;10:1012\u201321.","journal-title":"Am J Transl Res"},{"key":"1091_CR105","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.immuni.2021.04.021","volume":"54","author":"MB Buechler","year":"2021","unstructured":"Buechler MB, Fu W, Turley SJ. Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer. Immunity. 2021;54:903\u201315.","journal-title":"Immunity"},{"key":"1091_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-12-254","volume":"12","author":"X Chen","year":"2012","unstructured":"Chen X, Liu C, Lu Y, Yang Z, Lv Z, Xu Q, et al. Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats. BMC Complement Altern Med. 2012;12:254.","journal-title":"BMC Complement Altern Med"},{"key":"1091_CR107","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.intimp.2016.06.023","volume":"38","author":"Z Ma","year":"2016","unstructured":"Ma Z, Chu L, Liu H, Li J, Zhang Y, Liu W, Dai J, Yi J, Gao Y. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: involvement with the ROCK\/NF-kappaB pathway. Int Immunopharmacol. 2016;38:377\u201384.","journal-title":"Int Immunopharmacol"},{"key":"1091_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00326","volume":"8","author":"A Xiong","year":"2017","unstructured":"Xiong A, Liu Y. Targeting hypoxia inducible factors-1alpha as a novel therapy in fibrosis. Front Pharmacol. 2017;8:326.","journal-title":"Front Pharmacol"},{"key":"1091_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649463","volume":"12","author":"H Zhuang","year":"2021","unstructured":"Zhuang H, Lv Q, Zhong C, Cui Y, He L, Zhang C, et al. Tiliroside ameliorates ulcerative colitis by restoring the M1\/M2 macrophage balance via the HIF-1alpha\/glycolysis pathway. Front Immunol. 2021;12:649463.","journal-title":"Front Immunol"},{"key":"1091_CR110","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1142\/S0192415X2350057X","volume":"51","author":"Y Liu","year":"2023","unstructured":"Liu Y, He CY, Yang XM, Chen WC, Zhang MJ, Zhong XD, et al. Paeoniflorin coordinates macrophage polarization and mitigates liver inflammation and fibrogenesis by targeting the NF-[Formula: see text]B\/HIF-1alpha pathway in CCl(4)-induced liver fibrosis. Am J Chin Med. 2023;51:1249\u201367.","journal-title":"Am J Chin Med"},{"key":"1091_CR111","doi-asserted-by":"publisher","DOI":"10.1590\/acb361106","volume":"36","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang S, Luo X, Zhao H, Xiang X. Paeoniflorin mitigates PBC-induced liver fibrosis by repressing NLRP3 formation. Acta Cir Bras. 2022;36:e361106.","journal-title":"Acta Cir Bras"},{"key":"1091_CR112","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bjorkegren","year":"2022","unstructured":"Bjorkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185:1630\u201345.","journal-title":"Cell"},{"key":"1091_CR113","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","volume":"18","author":"L Sun","year":"2021","unstructured":"Sun L, Cai J, Gonzalez FJ. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. Nat Rev Gastroenterol Hepatol. 2021;18:335\u201347.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1091_CR114","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ni.2228","volume":"13","author":"H Wen","year":"2012","unstructured":"Wen H, Ting JP, O\u2019Neill LA. A role for the NLRP3 inflammasome in metabolic diseases\u2013did Warburg miss inflammation? Nat Immunol. 2012;13:352\u20137.","journal-title":"Nat Immunol"},{"key":"1091_CR115","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur GL, Jorgensen HF, Clarke MCH, Bennett MR, Mallat Z. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019;16:727\u201344.","journal-title":"Nat Rev Cardiol"},{"key":"1091_CR116","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/pr.118.017178","volume":"71","author":"D Wang","year":"2019","unstructured":"Wang D, Yang Y, Lei Y, Tzvetkov NT, Liu X, Yeung AWK, Xu S, Atanasov AG. Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev. 2019;71:596\u2013670.","journal-title":"Pharmacol Rev"},{"key":"1091_CR117","doi-asserted-by":"publisher","first-page":"9567","DOI":"10.3892\/mmr.2017.7776","volume":"16","author":"Y Guo","year":"2017","unstructured":"Guo Y, Zhao Y, Li L, Wei X, Gao P, Zhou Y, et al. Concentration\u2013dependent effects of paeoniflorin on proliferation and apoptosis of vascular smooth muscle cells. Mol Med Rep. 2017;16:9567\u201372.","journal-title":"Mol Med Rep"},{"key":"1091_CR118","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.intimp.2017.10.017","volume":"54","author":"W Li","year":"2018","unstructured":"Li W, Zhi W, Liu F, Zhao J, Yao Q, Niu X. Paeoniflorin inhibits VSMCs proliferation and migration by arresting cell cycle and activating HO-1 through MAPKs and NF-kappaB pathway. Int Immunopharmacol. 2018;54:103\u201311.","journal-title":"Int Immunopharmacol"},{"key":"1091_CR119","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s10753-017-0644-z","volume":"40","author":"H Li","year":"2017","unstructured":"Li H, Jiao Y, Xie M. Paeoniflorin ameliorates atherosclerosis by suppressing TLR4-mediated NF-kappaB activation. Inflammation. 2017;40:2042\u201351.","journal-title":"Inflammation"},{"key":"1091_CR120","doi-asserted-by":"publisher","first-page":"9291","DOI":"10.1002\/jcb.28204","volume":"120","author":"Y Wang","year":"2019","unstructured":"Wang Y, Che J, Zhao H, Tang J, Shi G. Paeoniflorin attenuates oxidized low-density lipoprotein-induced apoptosis and adhesion molecule expression by autophagy enhancement in human umbilical vein endothelial cells. J Cell Biochem. 2019;120:9291\u20139.","journal-title":"J Cell Biochem"},{"key":"1091_CR121","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3892\/ijmm.2012.1211","volume":"31","author":"JZ Li","year":"2013","unstructured":"Li JZ, Wu JH, Yu SY, Shao QR, Dong XM. Inhibitory effects of paeoniflorin on lysophosphatidylcholine-induced inflammatory factor production in human umbilical vein endothelial cells. Int J Mol Med. 2013;31:493\u20137.","journal-title":"Int J Mol Med"},{"key":"1091_CR122","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1080\/13880209.2023.2220360","volume":"61","author":"S Liu","year":"2023","unstructured":"Liu S, Li Y, Wu C. Paeoniflorin suppresses the apoptosis and inflammation of human coronary artery endothelial cells induced by oxidized low-density lipoprotein by regulating the Wnt\/beta-catenin pathway. Pharm Biol. 2023;61:1454\u201361.","journal-title":"Pharm Biol"},{"key":"1091_CR123","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm1102-1235","volume":"8","author":"AC Li","year":"2002","unstructured":"Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med. 2002;8:1235\u201342.","journal-title":"Nat Med"},{"key":"1091_CR124","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/S0022-2275(20)31498-X","volume":"42","author":"AD Attie","year":"2001","unstructured":"Attie AD, Kastelein JP, Hayden MR. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res. 2001;42:1717\u201326.","journal-title":"J Lipid Res"},{"key":"1091_CR125","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1172\/JCI59817","volume":"122","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Breevoort SR, Angdisen J, Fu M, Schmidt DR, Holmstrom SR, Kliewer SA, Mangelsdorf DJ, Schulman IG. Liver LXRalpha expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest. 2012;122:1688\u201399.","journal-title":"J Clin Invest"},{"key":"1091_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176137","volume":"961","author":"R Man Wu","year":"2023","unstructured":"Man Wu R, Wang CY, Wang J, Xu XL. Promoting reverse cholesterol transport contributes to the amelioration of atherosclerosis by Paeoniflorin. Eur J Pharmacol. 2023;961:176137.","journal-title":"Eur J Pharmacol"},{"key":"1091_CR127","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the L","year":"2009","unstructured":"European Association for the Study of the L. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237\u201367.","journal-title":"J Hepatol"},{"key":"1091_CR128","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00204-019-02437-2","volume":"93","author":"E Gijbels","year":"2019","unstructured":"Gijbels E, Vilas-Boas V, Deferm N, Devisscher L, Jaeschke H, Annaert P, et al. Mechanisms and in vitro models of drug-induced cholestasis. Arch Toxicol. 2019;93:1169\u201386.","journal-title":"Arch Toxicol"},{"key":"1091_CR129","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.28991","volume":"65","author":"M Trauner","year":"2017","unstructured":"Trauner M, Fuchs CD, Halilbasic E, Paumgartner G. New therapeutic concepts in bile acid transport and signaling for management of cholestasis. Hepatology. 2017;65:1393\u2013404.","journal-title":"Hepatology"},{"key":"1091_CR130","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3748\/wjg.15.1677","volume":"15","author":"MJ Perez","year":"2009","unstructured":"Perez MJ, Briz O. Bile-acid-induced cell injury and protection. World J Gastroenterol. 2009;15:1677\u201389.","journal-title":"World J Gastroenterol"},{"key":"1091_CR131","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.MPG.0000170600.80640.88","volume":"41","author":"RJ Sokol","year":"2005","unstructured":"Sokol RJ, Dahl R, Devereaux MW, Yerushalmi B, Kobak GE, Gumpricht E. Human hepatic mitochondria generate reactive oxygen species and undergo the permeability transition in response to hydrophobic bile acids. J Pediatr Gastroenterol Nutr. 2005;41:235\u201343.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1091_CR132","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.biopha.2017.02.084","volume":"89","author":"HQ Zhou","year":"2017","unstructured":"Zhou HQ, Liu W, Wang J, Huang YQ, Li PY, Zhu Y, et al. Paeoniflorin attenuates ANIT-induced cholestasis by inhibiting apoptosis in vivo via mitochondria-dependent pathway. Biomed Pharmacother. 2017;89:696\u2013704.","journal-title":"Biomed Pharmacother"},{"key":"1091_CR133","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02245-0","author":"W Zhang","year":"2025","unstructured":"Zhang W, Wang Z, Sun R, Zeng Y, Chen Y, Hu Q, et al. Exploration of the combined mechanism of direct and indirect effects of paeoniflorin in the treatment of cholestasis. Inflammation. 2025. https:\/\/doi.org\/10.1007\/s10753-025-02245-0.","journal-title":"Inflammation"},{"key":"1091_CR134","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S1050-1738(00)00043-8","volume":"10","author":"H Tu","year":"2000","unstructured":"Tu H, Okamoto AY, Shan B. FXR, a bile acid receptor and biological sensor. Trends Cardiovasc Med. 2000;10:30\u20135.","journal-title":"Trends Cardiovasc Med"},{"key":"1091_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1064653","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Yuan T, Sun J, Yang M, Chen Y, Wang L, et al. Paeoniflorin alleviates 17alpha-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats. Front Pharmacol. 2022;13:1064653.","journal-title":"Front Pharmacol"},{"key":"1091_CR136","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biopha.2017.02.025","volume":"89","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, He X, Ma X, Wen J, Li P, Wang J, et al. Paeoniflorin ameliorates cholestasis via regulating hepatic transporters and suppressing inflammation in ANIT-fed rats. Biomed Pharmacother. 2017;89:61\u20138.","journal-title":"Biomed Pharmacother"},{"key":"1091_CR137","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/toxsci\/kfp020","volume":"108","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Aleksunes LM, Cui YJ, Klaassen CD. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. Toxicol Sci. 2009;108:247\u201357.","journal-title":"Toxicol Sci"},{"key":"1091_CR138","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/s-0030-1253227","volume":"30","author":"A Kosters","year":"2010","unstructured":"Kosters A, Karpen SJ. The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis. 2010;30:186\u201394.","journal-title":"Semin Liver Dis"},{"key":"1091_CR139","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0030-1253228","volume":"30","author":"BL Copple","year":"2010","unstructured":"Copple BL, Jaeschke H, Klaassen CD. Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis. 2010;30:195\u2013204.","journal-title":"Semin Liver Dis"},{"key":"1091_CR140","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/CIRCRESAHA.112.267054","volume":"110","author":"K Schroder","year":"2012","unstructured":"Schroder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, et al. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res. 2012;110:1217\u201325.","journal-title":"Circ Res"},{"key":"1091_CR141","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/ptr.5431","volume":"29","author":"Z Chen","year":"2015","unstructured":"Chen Z, Ma X, Zhu Y, Zhao Y, Wang J, Li R, et al. Paeoniflorin ameliorates ANIT-induced cholestasis by activating Nrf2 through an PI3K\/Akt-dependent pathway in rats. Phytother Res. 2015;29:1768\u201375.","journal-title":"Phytother Res"},{"key":"1091_CR142","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.fct.2013.04.030","volume":"58","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhou G, Wang J, Jia L, Zhang P, Li R, et al. Paeoniflorin protects against ANIT-induced cholestasis by ameliorating oxidative stress in rats. Food Chem Toxicol. 2013;58:242\u20138.","journal-title":"Food Chem Toxicol"},{"key":"1091_CR143","doi-asserted-by":"crossref","unstructured":"Stener-Victorin E, Deng Q. Epigenetic inheritance of PCOS by developmental programming and germline transmission. Trends Endocrinol Metab 2025;36:472-81.","DOI":"10.1016\/j.tem.2024.12.002"},{"key":"1091_CR144","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-024-00601-4","volume":"14","author":"C Johnson","year":"2025","unstructured":"Johnson C, Garipoglu G, Jeanes Y, Frontino G, Costabile A. The role of diet, glycaemic index and glucose control in polycystic ovary syndrome (PCOS) management and mechanisms of progression. Curr Nutr Rep. 2025;14:8.","journal-title":"Curr Nutr Rep"},{"key":"1091_CR145","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.18632\/aging.202564","volume":"13","author":"J Zhou","year":"2021","unstructured":"Zhou J, Tan Y, Wang X, Zhu M. Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-beta1\/Smads signaling pathway in vivo. Aging. 2021;13:7084\u201395.","journal-title":"Aging"},{"key":"1091_CR146","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jep.2018.09.006","volume":"229","author":"M Ong","year":"2019","unstructured":"Ong M, Cheng J, Jin X, Lao W, Johnson M, Tan Y, et al. Paeoniflorin extract reverses dexamethasone-induced testosterone over-secretion through downregulation of cytochrome P450 17A1 expression in primary murine theca cells. J Ethnopharmacol. 2019;229:97\u2013103.","journal-title":"J Ethnopharmacol"},{"key":"1091_CR147","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.apsb.2019.10.001","volume":"9","author":"Y Li","year":"2019","unstructured":"Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, et al. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B. 2019;9:1113\u201344.","journal-title":"Acta Pharm Sin B"},{"key":"1091_CR148","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.2042-7158.1995.tb03293.x","volume":"47","author":"S Takeda","year":"1995","unstructured":"Takeda S, Isono T, Wakui Y, Matsuzaki Y, Sasaki H, Amagaya S, et al. Absorption and excretion of paeoniflorin in rats. J Pharm Pharmacol. 1995;47:1036\u201340.","journal-title":"J Pharm Pharmacol"},{"key":"1091_CR149","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fphar.2019.00268","volume":"10","author":"JB Yu","year":"2019","unstructured":"Yu JB, Zhao ZX, Peng R, Pan LB, Fu J, Ma SR, Han P, Cong L, Zhang ZW, Sun LX, et al. Gut Microbiota-Based pharmacokinetics and the antidepressant mechanism of Paeoniflorin. Front Pharmacol. 2019;10:268.","journal-title":"Front Pharmacol"},{"key":"1091_CR150","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1007\/s11095-006-9100-8","volume":"23","author":"ZQ Liu","year":"2006","unstructured":"Liu ZQ, Jiang ZH, Liu L, Hu M. Mechanisms responsible for poor oral bioavailability of paeoniflorin: role of intestinal disposition and interactions with sinomenine. Pharm Res. 2006;23:2768\u201380.","journal-title":"Pharm Res"},{"key":"1091_CR151","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.2042-7158.1997.tb06748.x","volume":"49","author":"S Takeda","year":"1997","unstructured":"Takeda S, Isono T, Wakui Y, Mizuhara Y, Amagaya S, Maruno M, et al. In-vivo assessment of extrahepatic metabolism of paeoniflorin in rats: relevance to intestinal floral metabolism. J Pharm Pharmacol. 1997;49:35\u20139.","journal-title":"J Pharm Pharmacol"},{"key":"1091_CR152","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1248\/cpb.33.3838","volume":"33","author":"M Hattori","year":"1985","unstructured":"Hattori M, Shu YZ, Shimizu M, Hayashi T, Morita N, Kobashi K, et al. Metabolism of paeoniflorin and related compounds by human intestinal bacteria. Chem Pharm Bull (Tokyo). 1985;33:3838\u201346.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"1091_CR153","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jchromb.2003.11.040","volume":"802","author":"X He","year":"2004","unstructured":"He X, Xing D, Ding Y, Li Y, Xiang L, Wang W, et al. Determination of paeoniflorin in rat hippocampus by high-performance liquid chromatography after intravenous administration of paeoniae radix extract. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;802:277\u201381.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1091_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21030300","volume":"21","author":"PY Hu","year":"2016","unstructured":"Hu PY, Liu D, Zheng Q, Wu Q, Tang Y, Yang M. Elucidation of transport mechanism of paeoniflorin and the influence of Ligustilide, Senkyunolide I and Senkyunolide A on paeoniflorin transport through Mdck-Mdr1 cells as Blood-Brain barrier in vitro model. Molecules. 2016;21:300.","journal-title":"Molecules"},{"key":"1091_CR155","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1379\/CSC-51R.1","volume":"9","author":"D Yan","year":"2004","unstructured":"Yan D, Saito K, Ohmi Y, Fujie N, Ohtsuka K. Paeoniflorin, a novel heat shock protein-inducing compound. Cell Stress Chaperones. 2004;9:378\u201389.","journal-title":"Cell Stress Chaperones"},{"key":"1091_CR156","first-page":"351","volume":"5","author":"S Fang","year":"2012","unstructured":"Fang S, Zhu W, Zhang Y, Shu Y, Liu P. Paeoniflorin modulates multidrug resistance of a human gastric cancer cell line via the inhibition of NF-kappaB activation. Mol Med Rep. 2012;5:351\u20136.","journal-title":"Mol Med Rep"},{"key":"1091_CR157","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.clinthera.2015.12.005","volume":"38","author":"X Li","year":"2016","unstructured":"Li X, Shi F, Zhang R, Sun C, Gong C, Jian L, et al. Pharmacokinetics, safety, and tolerability of amygdalin and Paeoniflorin after single and multiple intravenous infusions of Huoxue-Tongluo lyophilized powder for injection in healthy Chinese volunteers. Clin Ther. 2016;38:327\u201337.","journal-title":"Clin Ther"},{"key":"1091_CR158","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.phymed.2018.02.006","volume":"44","author":"Z Li","year":"2018","unstructured":"Li Z, Liu J, Zhang D, Du X, Han L, Lv C, et al. Nuciferine and paeoniflorin can be quality markers of Tangzhiqing tablet, a Chinese traditional patent medicine, based on the qualitative, quantitative and dose-exposure-response analysis. Phytomedicine. 2018;44:155\u201363.","journal-title":"Phytomedicine"},{"key":"1091_CR159","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","volume":"65","author":"M Estudante","year":"2013","unstructured":"Estudante M, Morais JG, Soveral G, Benet LZ. Intestinal drug transporters: an overview. Adv Drug Deliv Rev. 2013;65:1340\u201356.","journal-title":"Adv Drug Deliv Rev"},{"key":"1091_CR160","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/13880209.2021.1875013","volume":"59","author":"Q Chen","year":"2021","unstructured":"Chen Q, Yin C, Li Y, Yang Z, Tian Z. Pharmacokinetic interaction between peimine and paeoniflorin in rats and its potential mechanism. Pharm Biol. 2021;59:129\u201333.","journal-title":"Pharm Biol"},{"key":"1091_CR161","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11418-016-1049-2","volume":"71","author":"R He","year":"2017","unstructured":"He R, Xu Y, Peng J, Ma T, Li J, Gong M. The effects of 18beta-glycyrrhetinic acid and glycyrrhizin on intestinal absorption of paeoniflorin using the everted rat gut sac model. J Nat Med. 2017;71:198\u2013207.","journal-title":"J Nat Med"},{"key":"1091_CR162","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/13880209.2019.1651876","volume":"57","author":"H Sun","year":"2019","unstructured":"Sun H, Wang J, Lv J. Effects of glycyrrhizin on the pharmacokinetics of paeoniflorin in rats and its potential mechanism. Pharm Biol. 2019;57:550\u20134.","journal-title":"Pharm Biol"},{"key":"1091_CR163","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/03639045.2020.1862178","volume":"47","author":"C Shen","year":"2021","unstructured":"Shen C, Shen B, Zhu J, Wang J, Yuan H, Li X. Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin. Drug Dev Ind Pharm. 2021;47:207\u201314.","journal-title":"Drug Dev Ind Pharm"},{"key":"1091_CR164","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jep.2005.08.020","volume":"103","author":"K Chan","year":"2006","unstructured":"Chan K, Liu ZQ, Jiang ZH, Zhou H, Wong YF, Xu HX, et al. The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model. J Ethnopharmacol. 2006;103:425\u201332.","journal-title":"J Ethnopharmacol"},{"key":"1091_CR165","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jep.2005.01.052","volume":"99","author":"ZQ Liu","year":"2005","unstructured":"Liu ZQ, Zhou H, Liu L, Jiang ZH, Wong YF, Xie Y, et al. Influence of co-administrated Sinomenine on pharmacokinetic fate of Paeoniflorin in unrestrained conscious rats. J Ethnopharmacol. 2005;99:61\u20137.","journal-title":"J Ethnopharmacol"},{"key":"1091_CR166","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jpba.2005.11.004","volume":"41","author":"XG Yang","year":"2006","unstructured":"Yang XG, Peng B, Zhang GH, Wei LL, Nie SF, Pan WS. Studies of the pharmacokinetics of Paeoniflorin in two Jing-Zhi-Guan-Xin formulations after oral administration to beagle dogs. J Pharm Biomed Anal. 2006;41:320\u20134.","journal-title":"J Pharm Biomed Anal"},{"key":"1091_CR167","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s13318-023-00825-9","volume":"48","author":"WC Chen","year":"2023","unstructured":"Chen WC, Liang XY, Xie LY, Wu MA, Shen Q, Yao LM, et al. Comparative study on the pharmacokinetics of Paeoniflorin, white peony root water extract, and Taohong Siwu Decoction after oral administration in rats. Eur J Drug Metab Pharmacokinet. 2023;48:301\u201310.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1091_CR168","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3109\/00498254.2016.1149633","volume":"46","author":"C Wang","year":"2016","unstructured":"Wang C, Yuan J, Zhang LL, Wei W. Pharmacokinetic comparisons of Paeoniflorin and Paeoniflorin-6\u2019O-benzene sulfonate in rats via different routes of administration. Xenobiotica. 2016;46:1142\u201350.","journal-title":"Xenobiotica"},{"key":"1091_CR169","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10787-018-0463-3","volume":"27","author":"M Zhao","year":"2019","unstructured":"Zhao M, Zhou P, Yu J, James A, Xiao F, Wang C, Wei W. The tissue distribution and excretion study of paeoniflorin-6\u2019-O-benzene sulfonate (CP-25) in rats. Inflammopharmacology. 2019;27:969\u201374.","journal-title":"Inflammopharmacology"},{"key":"1091_CR170","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/ptr.6870","volume":"35","author":"XY Cai","year":"2021","unstructured":"Cai XY, Ge JR, Xu L, Liang FQ, Zhu Y, Tai Y, et al. Paeoniflorin-6\u2019-o-benzene sulfonate (CP-25) improves vasculitis through inhibiting IL-17A\/JAK\/STAT3 signaling pathway in endothelial cells of HFD CIA rats. Phytother Res. 2021;35:1033\u201347.","journal-title":"Phytother Res"},{"key":"1091_CR171","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41374-020-0453-0","volume":"101","author":"H Wu","year":"2021","unstructured":"Wu H, Chen X, Gu F, Zhang P, Xu S, Liu Q, Zhang Q, Wang X, Wang C, Korner H, Wei W. CP-25 alleviates antigen-induced experimental sjogren\u2019s syndrome in mice by inhibiting JAK1-STAT1\/2-CXCL13 signaling and interfering with B-cell migration. Lab Invest. 2021;101:1084\u201397.","journal-title":"Lab Invest"},{"key":"1091_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108601","volume":"694","author":"J Zhang","year":"2020","unstructured":"Zhang J, Liu Y, Long M, Li J, Zhao W, Su Q. Inhibitory effect of CP-25 on intimal formation and vascular hyperplasia via suppression of GRK2\/ERK1\/2\/EVI1 signaling. Arch Biochem Biophys. 2020;694:108601.","journal-title":"Arch Biochem Biophys"},{"key":"1091_CR173","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41401-020-00510-6","volume":"41","author":"XZ Yang","year":"2020","unstructured":"Yang XZ, Wei W. CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacol Sin. 2020;41:1387\u201394.","journal-title":"Acta Pharmacol Sin"},{"key":"1091_CR174","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000514321","volume":"34","author":"J Huang","year":"2021","unstructured":"Huang J, Cui Y, Yang Y, Li H, Zhang Y, Yang H, et al. Optical coherence tomography and microdialysis for microneedle-mediated penetration enhancement study of Paeoniflorin-loaded ethosomes. Skin Pharmacol Physiol. 2021;34:183\u201393.","journal-title":"Skin Pharmacol Physiol"},{"key":"1091_CR175","doi-asserted-by":"publisher","first-page":"22113","DOI":"10.1039\/D4RA03419H","volume":"14","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Wei Q, Du L, Guo Z, Li Y. In vitro evaluation and in situ intestinal absorption characterisation of Paeoniflorin nanoparticles in a rat model. RSC Adv. 2024;14:22113\u201322.","journal-title":"RSC Adv"},{"key":"1091_CR176","first-page":"326","volume":"15","author":"C Wu","year":"2020","unstructured":"Wu C, Li B, Zhang Y, Chen T, Chen C, Jiang W, et al. Intranasal delivery of Paeoniflorin nanocrystals for brain targeting. Asian J Pharm Sci. 2020;15:326\u201335.","journal-title":"Asian J Pharm Sci"},{"key":"1091_CR177","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","volume":"51","author":"N Musi","year":"2002","unstructured":"Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes. 2002;51:2074\u201381.","journal-title":"Diabetes"},{"key":"1091_CR178","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1161\/CIRCULATIONAHA.116.025678","volume":"135","author":"AV Khera","year":"2017","unstructured":"Khera AV, Demler OV, Adelman SJ, Collins HL, Glynn RJ, Ridker PM, et al. Cholesterol efflux capacity, High-Density lipoprotein particle Number, and incident cardiovascular events: an analysis from the JUPITER trial (Justification for the use of Statins in prevention: an intervention trial evaluating Rosuvastatin). Circulation. 2017;135:2494\u2013504.","journal-title":"Circulation"},{"key":"1091_CR179","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1111\/dom.16508","volume":"27","author":"A Ciudin","year":"2025","unstructured":"Ciudin A, Johansson E, Zimner-Rapuch S, Dimitriadis GK, Bertrand M, Curteis T, et al. Indirect comparative efficacy and safety of Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes. Diabetes Obes Metab. 2025;27:4709\u201319.","journal-title":"Diabetes Obes Metab"},{"key":"1091_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176917","volume":"981","author":"L Meng","year":"2024","unstructured":"Meng L, Lv H, Kong Q, Li S, Jiang N, Yu C, et al. The combination of Paeoniflorin and Metformin synergistically inhibits the progression of liver fibrosis in mice. Eur J Pharmacol. 2024;981:176917.","journal-title":"Eur J Pharmacol"},{"key":"1091_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114569","volume":"205","author":"P Kumar","year":"2024","unstructured":"Kumar P, Bhardwaj VK, Shende P, Purohit R. Computational and experimental analysis of Luteolin-beta-cyclodextrin supramolecular complexes: insights into conformational dynamics and phase solubility. Eur J Pharm Biopharm. 2024;205:114569.","journal-title":"Eur J Pharm Biopharm"},{"key":"1091_CR182","doi-asserted-by":"crossref","unstructured":"Zhang W, Wei B, Li S, Wang Y, Wang S. Preparation and chromatographic application of beta-Cyclodextrin molecularly imprinted microspheres for Paeoniflorin. Polym (Basel). 2017;9:214.","DOI":"10.3390\/polym9060214"},{"key":"1091_CR183","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s13258-024-01553-3","volume":"46","author":"S Lee","year":"2024","unstructured":"Lee S, Park NI, Park Y, Heo K, Kwon Y, Kim ES, et al. Contents of Paeoniflorin and Albiflorin in two Korean landraces of paeonia lactiflora and characterization of Paeoniflorin biosynthesis genes in peony. Genes Genomics. 2024;46:1107\u201322.","journal-title":"Genes Genomics"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-026-01091-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-026-01091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:03:25Z","timestamp":1779926605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12986-026-01091-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/s12986-026-01091-7","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The manuscript has been approved by all authors for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}